Prevalence and socio-economic aspects of chronic kidney disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The incidence and prevalence of end-stage renal disease (ESRD) are rising in Europe, the USA, and Japan. Prevalence is rising more steeply than incidence, due mostly to improved efficiency of treatment -patients are surviving longer. Hypertension and diabetes, the main causes of progression from chronic kidney disease (CKD) to ESRD, are becoming more frequent in the general population and make a large contribution to the rising incidence of ESRD. More effective therapies for other conditions have introduced new complications for patients with CKD, thereby also increasing the incidence of ESRD. Increased survival in the general population is reflected in the greater number of elderly people requiring care for ESRD. ESRD is a great economic burden and one that will increase as the incidence and prevalence of the disease increase. This needs to be considered when planning treatment. Prevention and early treatment of hypertension and diabetes will have the greatest impact on the future prevalence of ESRD and the costs associated with its treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Cited by
Obesity and Risk for Chronic Renal Failure
Ejerblad, E., Fored, C. M., Lindblad, P., Fryzek, J., McLaughlin, J. K., & Nyrén, O. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005060638 · Cited by 680
The burden of kidney disease: Improving global outcomes
Eknoyan, G., Lameire, N., Barsoum, R., Eckardt, K.-U., Levin, A., Levin, N., Locatelli, F., Macleod, A., Vanholder, R., Walker, R., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00894.x · Cited by 519
Prevalence of Chronic Kidney Disease and Associated Risk Factors—United States, 1999-2004
(2007) · JAMA · doi:10.1001/jama.297.16.1767 · Cited by 254
Podocytes maintain high basal levels of autophagy independent of mtor signaling
Bork, T., Liang, W., Yamahara, K., Lee, P., Tian, Z., Liu, S., Schell, C., Thedieck, K., Hartleben, B., Patel, K., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1705007 · Cited by 100
“Glomerular diseases and diabetic nephropathy (DN) are the leading cause for ESRD in developed countries, indicating the importance of intact glomeruli and podocytes for maintaining renal integrity [50].”
BackgroundDijkstra, R. F., Niessen, L. W., Braspenning, J. C. C., Adang, E., & Grol, R. T. P. M. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01751.x · Cited by 81
Metadata
- Authors
- Bommer, J.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-11-01
- Volume
- 17
- Issue
- suppl 11
- Pages
- 8-12
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2134891180
- Cited by
- 83
- References
- 2
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and socio-economic aspects of chronic kidney disease. https://app.cochat.ai/papers/10.1093/ndt/17.suppl_11.8
- The paper
- Bommer, J. (2002). Prevalence and socio-economic aspects of chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/17.suppl_11.8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.